OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid · OpenFeds · OpenSpending

© 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodology•Download Data
  1. Home
  2. Procedures
  3. J1745
  4. Cost Analysis

How Much Does Injection, infliximab, excludes biosimilar, 10 mg Cost on Medicare?

Cost analysis for CPT J1745 — Injection, infliximab, excludes biosimilar, 10 mg

Share:

Average Medicare Payment

N/A

Total Payments (Latest)

N/A

Services (Latest)

N/A

Price Change (–)

N/A

🗺️ State-by-State Cost Variation

The most expensive state pays 1.0x more than the cheapest for this procedure. SD averages $26.29 vs NH at $25.08.

StateAvg PaymentTotal PaymentsServicesProviders
SD$26.29$485.9K18.5K5
MS$26.25$1.7M66.7K20
ME$26.19$364.1K13.9K3
MI$26.16$1.5M59.1K20
FL$26.16$9.8M374.3K121
NY$26.13$6.2M237.5K50
AR$26.10$921.1K35.3K9
MD$26.09$4.8M183.7K44
IA$26.08$1.9M74.3K21
ID$26.08$787.6K30.2K4
AK$26.03$705.0K27.1K3
RI$26.02$260.0K10.0K4
NE$26.02$2.7M102.1K37
VA$26.01$5.8M223.1K29
IL$26.01$5.4M209.4K64
OH$26.00$5.3M204.0K38
NC$26.00$8.9M343.0K76
MT$26.00$367.4K14.1K3
IN$25.97$2.3M87.3K19
KS$25.95$2.0M78.4K21
AL$25.93$2.8M107.5K26
WA$25.93$5.0M193.5K45
UT$25.91$959.9K37.1K7
CO$25.90$4.0M153.7K36
NV$25.89$463.8K17.9K2
LA$25.89$640.2K24.7K8
DC$25.87$52.3K2.0K2
PA$25.86$8.9M343.8K77
WI$25.85$2.5M98.0K15
MN$25.84$4.3M166.2K56
AZ$25.79$3.9M153.0K38
OR$25.79$2.3M89.4K20
CT$25.78$700.4K27.2K11
SC$25.77$5.0M195.2K47
TX$25.76$9.6M372.8K106
TN$25.73$4.8M185.5K41
NJ$25.70$3.8M148.8K29
MO$25.69$4.5M174.7K38
DE$25.67$1.2M47.1K9
NM$25.61$178.0K7.0K4
OK$25.61$4.4M170.7K14
GA$25.60$2.4M94.3K25
KY$25.58$1.0M40.2K11
HI$25.54$129.2K5.1K1
CA$25.36$6.7M262.7K69
ND$25.24$38.1K1.5K1
MA$25.19$1.8M71.1K15
NH$25.08$392.8K15.7K8

💰 Who Bills the Most for This Procedure?

ProviderSpecialtyStatePaymentsServicesAvg/Service
Craig CarsonRheumatologyOK$1.5M60.8K$25.39
Stephen SolowayRheumatologyNJ$978.5K37.8K$25.88
Robert LagroneRheumatologyTN$798.2K30.5K$26.14
Ana KumarRheumatologyOK$771.8K30.2K$25.60
Nehal GandhiRheumatologyPA$740.2K29.1K$25.45
Ramzi KhairallahRheumatologyNY$696.8K26.7K$26.14
Keshav PandayRheumatologyOK$670.3K26.2K$25.59
Robert BrennanInfectious DiseaseVA$654.3K26.0K$25.13
Joy SchechtmanRheumatologyAZ$635.7K24.9K$25.52
Howard HauptmanRheumatologyMD$623.7K24.1K$25.90
Elena FlaggRheumatologyVA$613.9K23.4K$26.26
Laila RahbarRheumatologyVA$609.6K23.2K$26.26
Daniel WatrousRheumatologyCA$604.3K23.0K$26.31
Akgun InceRheumatologyMO$566.5K21.8K$25.99
Michael JosephRheumatologyMO$566.0K21.5K$26.36
Michael StrachanRheumatologyVA$546.2K20.8K$26.32
May AzemRheumatologyOH$529.7K20.3K$26.15
Michael ThakorRheumatologyCO$492.2K18.9K$26.07
John BotsonRheumatologyAK$468.1K18.1K$25.91
John AlbertRheumatologyWI$446.8K17.1K$26.17

🤔 Is Injection, infliximab, excludes biosimilar, 10 mg Overpriced?

Based on the data, CPT J1745 shows a 1.0x variation in pricing across states — relatively consistent by Medicare standards.

Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.

This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.

Data Sources

  • • Centers for Medicare & Medicaid Services (CMS)
  • • Medicare Provider Utilization and Payment Data (2014-2023)
  • • Medicare Physician Fee Schedule

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.